Invention Grant
- Patent Title: Sn-2-monoacylglycerols and lipid malabsorption
-
Application No.: US15581558Application Date: 2017-04-28
-
Publication No.: US10039742B2Publication Date: 2018-08-07
- Inventor: Bruce Bistrian , Frederic Destaillats , Cristina Cruz-Hernandez , Fabiola Dionisi , Isabelle Masserey-Elmelegy , Manuel Oliveira , Julie Celine Moulin
- Applicant: Nestec S.A. , Beth Israel Deaconess Medical Center, Inc.
- Applicant Address: CH Vevey US MA Boston
- Assignee: Nestec S.A.,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee: Nestec S.A.,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee Address: CH Vevey US MA Boston
- Agency: K&L Gates LLP
- Priority: EP10168420 20100705
- Main IPC: A01N43/02
- IPC: A01N43/02 ; A61K31/335 ; A61K31/357 ; A61K31/232 ; A23K20/158 ; A23L2/52 ; A23L33/12
Abstract:
The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.
Public/Granted literature
- US20170296507A1 SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION Public/Granted day:2017-10-19
Information query
IPC分类:
